2020
DOI: 10.1136/annrheumdis-2020-eular.1441
|View full text |Cite
|
Sign up to set email alerts
|

Ab0286 efficacy and Safety of Intra-Articular Injection of Etanercept in Rheumatoid Arthritis Patients

Abstract: Background:Refractory mono-oligo-arthritis is still a challenging clinical situation in rheumatoid arthritis. Intra-articular corticosteroids are the first-line therapy; however, their efficacy is rather varying and many patients experience relapses within 6 months after injection.(1)Intra-articular anti-TNF has the potential of being less toxic and cost effective compared to its systemic usage.(2)Recent evidences have shown a reduction in the synthesis of either the T helper 1 cytokines or in the interleukin-… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles